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Background: Recent studies haveshown that ginsenoside Rg1, extracted from the dry roots of Panax notoginseng
as a traditional Asian medicine, plays an anti-fibrosis role in myocardial remodeling. However, the mechanism still
remains unclear. In the present study, we investigate the effect of ginsenoside Rg1on the collagenic remodeling of
myocardium in chronic thromboembolic pulmonary hypertension (CTEPH), and its potential mechanism.
Methods: A rat model of CTEPH was established by injecting thrombi through the jugular vein wice in2 weeks.
Four weeks later, four groups (Group A: normal rats + normal saline; Group B: normal rats + Rg1; Group C: CTEPH
model + normal saline; Group D: CTEPH model + Rg1) were established. Normal saline and Rg1 were administrated
by intraperitoneal injection. Ineach group, we measured the hemodynamic parameters, as well as the right ventricle to
left ventricle (RV/LV) thickness ratio. Myocardial tissue sections of the RV were stained by hematoxylin-eosin +gentian
violet and the morphological characteristics were observed by light microscopy. The matrix metalloproteinases (MMP) -
2 and −9 were detected by the western blot.
Results: Compared with Group A and Group B, the right ventricular systolic pressure was significantly increased in
Group C and significantly decreased in Group D. Compared with Group A and Group B, the RV/LV thickness ratio of the
rats was significantly higher in Group C and Group D. There was significant fibrosis with collagen in Group C compared
with Group A and Group B, and less significant changes in Group D were observed compared with those in Group C.
The expression of MMP-2 and MMP-9 exhibited a significant decrease in Group C and was also significantly decreased
in Group D compared withGroup A and Group B. Also, a negative linear relationship was shown between collagen-I
and the expression of MMP-2 and MMP-9.
Conclusions: Our animal study showed that ginsenoside Rg1 positively affects myocardial remodeling and pulmonary
hemodynamics in CTEPH. Upregulation of the expression of MMP-2 and MMP-9 could explain the beneficial effects of
ginsenoside Rg1 in CTEPH.
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Pulmonary hypertension is a pathophysiologic syndrome
resulting from different causes and is characterized by
increases in pulmonary artery pressure and pulmonary
vascular resistance [1,2]. Without treatment, this pro-
gressively deteriorating disease leads to right heart fail-
ure and eventually to death Therefore, attenuating right
ventricular myocardial remodeling and delaying the de-
terioration of heart function should be the focus and
basis of the treatment for pulmonary hypertension. The
main function of the myocardial collagen network struc-
ture is to support the structure of myocardial cellsto
maintain ventricular geometry and compliance. Collagen
deposition, composed of type I and type III collagen,
is one of the main elements of myocardial collagen
network remodeling [3]. Therefore, promoting the deg-
radation of collagen plays an important role in redu-
cing ventricular remodeling. Panax notoginseng saponins
(PNS), a type of saponin component, is extracted from
the dry roots of Panax notoginseng, which has a long
history of use as a remedy in traditional Asian medicine
[4]. Pharmacological studies have shown that the con-
tent of PNS reached as high as 8% to 12% andis the
major active component in Panax notoginseng roots [5].
The main effective components are ginsenoside Rg1,
ginsenoside Rb1 and notoginsenoside R1 [6-8] (Figure 1).
Recent studies have suggested that PNS is involved in
the expansion of blood vessels, the reductionpf oxy-
gen free radicals and the specific inhibition of vascular
smooth muscle receptor-gated Ca2+ channels [9,10]. The
study by Wu found that PNS can reduce the risk of
coronary restenosis after percutaneous transluminal cor-
onary angioplasty, an effect that was closely correlated
to the deposition of an extracellular matrix (especiallyof
collagen-I) during the repair of a coronary artery en-
dothelial injury [11]. Ithas been reported that in a rat
model with an infarcted myocardium, ginsenoside Rg1
significantly attenuated the development of myocardial
fibrosis [12]. Ginsenoside Rg1 could also possibly treatFigure 1 Chemical structures of the main effective components of thehepatic fibrosis by decreasing the expression of tumor
necrosis factor-α and reducing the secretion of phospho-
lipase A2, as seen in a rat model with liver cirrhosis [13].
The anti-fibrosis role of ginsenoside Rg1 in myocardial
remodeling still remains to be clarified.
This study aimed to investigate the changes in collagen
during right ventricular remodeling and its regulatory
mechanism in a rat model of chronic thromboembolic
pulmonary hypertension (CTEPH) treated with ginse-
noside Rg1 so that we can provide a new approach in
the treatment of anti-myocardial remodeling.
Methods
Animal preparation
Healthy male Sprague Dawley (SD) rats, weighing 250 g
to 300 g at the age of 2 months, were provided by the
Experimental Animal Center of Chongqing Medical Uni-
versity, China. The animals were allowed to drink and
eat freely, caged at 18°C to 20°C and in 65% to 70% rela-
tive humidity. All experimental procedures were con-
ducted in accordance with the Guiding Principles for the
Care and Use of Animals in Research and Teaching,
approved by the Institutional Animal Care and Use
Committee of Chongqing Medical University, China.
Reagents and instruments
The experiments used rabbit anti-matrix metallopro-
teinase (MMP)-2 polyclonal antibodies (Sigma, USA),
anti-MMP-9 polyclonal antibodies (Santa Cruz, USA),
DAB reagent (Boster Company, China), gentian violet
(GV) dye (Department of Histology and Embryology,
Chongqing Medical University, China), protein lysate
(Beijing Zhongshan Golden Bridge Biological, China),
goat anti-rabbit IgG-HRP (Sigma,USA), mouse anti-
β-actin monoclonal antibodies (Santa Cruz, USA), ginse-
noside Rg1 (Chinese National Institute for the Control
of Pharmaceutical and Biological Products, China), an
optical imaging system (Olympus, Japan), a medical
pathology image processing system (Axioskop40,ZEISS)total saponins of Panax notoginseng root.
Figure 2 Hemodynamics for the four different groups of rats
(n = 8 per group). Right ventricular systolic pressure for the four
groups: Group A: 25.2 ± 3.3 mmHg, Group B: 26.8 ± 2.1 mmHg,
Group C: 34.3 ± 4.2 mmHg, Group D: 28.6 ± 4.6 mmHg. Data are
expressed as means ± standard error of mean. * P < 0.001 vs Group A
and Group B; # P < 0.05 vs Group C; $ P < 0.05 vs Group A and
Group B.
Figure 3 RV/LV ratiofor the four different groups of rats (n = 8
per group). RV/LV ratio of free-wall thicknessfor the four groups:
Group A: 47.3 ± 7.3%, Group B: 48.2 ± 1.8%, Group C: 78.2 ± 4.2%,
Group D: 58.2 ± 5.3%. Data are expressed as means ± standard error
of the mean. * P < 0.001 vs Group A and Group B; # P < 0.05 vs
Group C; $ P < 0.05 vs Group A and Group B. LV, left ventricle; RV,
right ventricle.
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Optical biotechnology company, China).
Animal model
From a total of 32 SD rats, 16 were used to establish the
rat model of CTEPH. The preparationof the CTEPH rat
model was modified from that described before [14].
The day before embolization, a sample of 0.2 ml blood
was collected from the tail vein and placed in a sterile
tube under a 37°C water bath overnight. A thrombus
was placed in sterilized petri dishes and divided into
3 mm × 1 mm emboli. Rats were injected intraperitone-
ally with 10% chloral hydrate (0.3 gkg-1) for anesthesia.
The rats were fixed on the operating table and their
right external jugular vein was exposed after a neck inci-
sion. The rats were injected with a mixture of about 15
thrombotic emboli in 2 ml saline injected at a speed of
0.5 ml.min-1. The rats showed symptoms of cyanosis and
shortness of breath after injection. The needle was
pulled out after injection and the neck was sutured after
hemostasis. The CTEPH rat model was determined by
chest radiographs. The experiment was repeated twice in
2 weeks in the same way for a total of 4 weeks. Anti-
fibrinolytic tranexamic acid (12.5 mg.kg-1.d-1) was in-
jected into the whole peritoneum. Besides the 32 SD
rats, an additional two rats were killed in the pre-
experiment to identify the anesthetic dose of chloral hy-
drate used in our study.
Grouping and administration
Sixteen normal rats (8 in Group A and 8 in Group B)
and 16 CTEPH model rats (8 in Group C and 8 in
Group D) were given intraperitoneal injections of 0.9%
saline (2 ml.d-1) or PNS (100 mg.kg-1.d-1). The groups
were: Group A: normal rats + 0.9% saline; Group B: nor-
mal rats + Rg1; Group C: CTEPH model rats + 0.9% sa-
line; Group D: CTEPH model rats + Rg1. The injections
were givenonce daily for a total of 4 weeks.
Detection of hemodynamics in rats
The rats were injected intraperitoneally with 10% chloral
hydrate with a concentration of 0.3 g.kg-1 and were fixed
in a supine position. After4 weeks of intraperitoneal in-
jections, the right external jugular vein was isolated and
exposed after a center-right incision through the neck.
A PE-50 PVC catheter was inserted into the right ex-
ternal jugular vein slowly at 1 cm to 2 cm from the
superior vena cava, 2 cm to 3 cm from the right at-
rium, and 4 cm from the right ventricle. The biological
signal acquisition system was connected to record the
right ventricular systolic pressure according to the ca-
theter position judged bychanges of the pressure curve
waveform.Determination of ventricularfree-wall thickness
Animals were sacrificed by an overdose of chloral hy-
drate after the determination of the right ventricular
pressure. The heart was removed with saline rinse. The
right ventricular (RV) and left ventricular (LV) free wall
were cut from the heart. Through a cross section along
the mitral valve leaflets, the RV and LVfree-wall thick-
nesses were measured by microscope and the RV/LV
free-wall thickness ratio was calculated as an indicator
for right ventricular hypertrophy.
Hematoxylin-eosinexamination of myocardial tissue
From the tip of the right ventricle, 1 cm × 0.3 cm of free
myocardial tissue was taken and immersed in a 10%
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Butterfly shaped sections of 5-mm thickness were cut
and placed on glass microscope slides stained with he-
matoxylin and eosin (HE) for histological analysisusing
the pathological image processing system.Gentian violetstainingof myocardial tissue
To determinethe collagen deposition in myocardial tis-
sues, GV staining was used in the study. Myocardial tis-
sues were first dehydrated through a graded ethanol
series, dewaxed using xylene, immediately dehydrated
with 95% alcohol and 100% alcohol, GV dyed for 3 min
to 5 min and were mountedusing a neutral xylene resin.
Images wereacquired by an optical microscope (magnifi-
cation 400×) and five random fields in each section wereHE Staining
Group A
Group B  
Group C  
Group D  
Figure 4 Histopathological analysis of myocardial tissues from rats in
random fields were analyzed by microscope (400× magnification) eac
and eosin.analyzed. GV staining was determinedusing the Image
Pro PLUS software.
Western blotting
From the tip of the RV, a sample of 1 cm × 0.3 cm of
free myocardial tissue was taken and cut into pieces. A
protein lysis buffer was added and the samples were
quantified using Coomassie brilliant blue. Then 20-μg
protein samples were added to the sample buffer for so-
dium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE), the polyvinylidene fluoride (PVDF) mem-
branes were transferred and samples were incubated
with anti-MMP-2 antibodies (1:300) and anti-MMP-9
antibodies (1:500) at 4°C overnight. The membranes were
incubated with anti-rabbit HRP-IgG antibodies (1:2,000)
at room temperature for 1 h and were colored byVG Staining
the four groups were examined by HE and GV staining and five
h section (n = 8 per group). GV, gentian violet; HE, hematoxylin
MMP-2 72kDa
β-actin 42kDa
Figure 5 Effect of ginsenoside Rg1 onMMP-2 expressionfor the
four groups (n = 8 per group). MMP-2 expression in myocardial
tissuewas analyzed by western blot. Group A: 0.31 ± 0.03, Group B:
0.29 ± 0.04, Group C: 0.13 ± 0.02, Group D: 0.21 ± 0.04. Data are
expressed as means ± standard error of the mean. * P < 0.01 vs
Group A and Group B; # P < 0.05 vs Group C; $ P < 0.05 vs Group A
and Group B. MMP, matrix metalloproteinase.
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washed repeatedly. Fluorescence band integrated optical
density values were collected and the intensity of the
bandswas readusing the relative integral optical density.
Western blot images were analyzed by Bio-Rad’s Quan-
titive One software and corrected using mouse anti-
β-actin monoclonal antibodies.
Statistical analysis
Measurement dataare presented as mean ± standard
error of the mean. Differences between groups were ana-
lyzed by one-way ANOVA. A level of P < 0.05 was con-
sidered statistically significant. Statistical analysis was
done using the SPSSl0.0 statistical software.
Results
Effect of ginsenoside Rg1 on hemodynamics and RV/LV
ratio in rats
Compared with rats in Group A (25.2 ± 3.3 mmHg) and
Group B (26.8 ± 2.1 mmHg), CTEPH rats in Group C
had a significantly higher right ventricular systolic pres-
sure (34.3 ± 4.2 mmHg). The right ventricular systolic
pressure significantly decreased after ginsenoside Rg1
treatment in Group D (28.6 ± 4.6 mmHg) compared
with rats in Group C. However, the right ventricular sys-
tolic pressure in Group D was still significantly higher
than that in Group A and Group B (Figure 2).
Compared with rats in Group A (47.3 ± 7.3%) and
Group B (48.2 ± 1.8%), the RV/LV thickness ratio of
CTEPH rats was significantly higher in Group C (78.2 ±
4.2%). After ginsenoside Rg1 treatment, the RV/LV
thickness ratioalso increased significantly in Group D
(58.2 ± 5.3%), compared with Group A and Group B,
but was significantly decreased compared with CTEPH
rats in Group C (Figure 3).
Histopathological examinationusing hematoxylin and
eosin and gentian violet staining
The results of the histopathological analysis of the myo-
cardial tissues from rats in the four groups are shown in
Figure 4. For Group A and Group B rats, HE staining of
the RV showed that the myocardial cells were arranged
in neat rows, there was no inflammatory cell infiltration
and the myocardial fibers were arranged in neat rowsGV
staining of myocardial tissues showed that there was lit-
tle pink collagen content in the myocardial fibers in
Group A and Group B rats. GV staining for Group C
showed that there was marked myocardial cell hyper-
trophy, an increased presence of disorganized partial
nuclei, more inflammatory cell infiltration, disorganized
muscle fibers and a large amount of pink collagen in
myocardial fibers with significant fibrosisHowever, the
myocardial tissues had less significant changes in GroupD compared with those in Group C, suggesting alle-
viation of heart pathology by ginsenoside Rg1.
Effect of ginsenoside Rg1 on the expression of MMP-2
and MMP-9 in myocardial tissue
Compared with rats in Group A (0.31 ± 0.03) and Group
B (0.29 ± 0.04), the expression of MMP-2 in CTEPH rats
in Group C (0.13 ± 0.02) exhibited a significant decrease.
The expression of MMP-2 also significantly decreased
after ginsenoside Rg1 treatment in Group D (0.21 ±0.04)
compared with rats in Group A and Group B. However,
the expression of MMP-2 in Group D was still signifi-
cantly higher than that in Group C (Figure 5).
As for the expression of MMP-2, the expression of
MMP-9 of CTEPH rats in Group C (0.14 ± 0.03) ex-
hibited a significant decrease compared with rats in
Group A (0.46 ± 0.07) and Group B (0.53 ± 0.06). The
expression of MMP-9 also significantly decreased after
ginsenoside Rg1 treatment in Group D (0.28 ±0.06)
compared with rats in Group A and Group B. However,
the expression of MMP-9 in Group D was still signifi-
cantly higher than that in Group C (Figure 6).
Correlationbetween the expression of MMP-2 or MMP-9
and collagen-I
In Group D, the relationship between collagen-I
(expressed as the collagen volume fraction) and the ex-
pression of MMP-2 and MMP-9 was further determined
using Pearson’s correlationFor the expression of MMP-2
and collagen-I, the collagen volume fractions were
MMP-9 92kDa  
β-actin 42kDa  
Figure 6 Effect of ginsenoside Rg1 onMMP-9 expression for the
four groups (n = 8 per group). MMP-9 expression in myocardial
tissuewas analyzed by western blot. Group A: 0.46 ± 0.07, Group B:
0.53 ± 0.06, Group C: 0.14 ± 0.03, Group D: 0.28 ± 0.06. Data are
expressed as means ± standard error of the mean. * P < 0.01 vs
Group A and Group B; # P < 0.05 vs Group C; $ P < 0.05 vs Group A
and Group B. MMP, matrix metalloproteinase.
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0.02, 4.80 ± 0.17, 4.86 ± 0.24, 4.90 ± 0.02for each sample,
respectively. For the expression of MMP-9 and collagen-I,
the collagen volume fractions were 3.6 ± 0.25, 3.8 ± 0.09,
4.0 ± 0.20, 4.2 ± 0.13, 4.4 ± 0.25, 4.6 ± 0.08, 4.8 ± 0.1730,
5.0 ± 0.01 for each sample respectively. Pearson’s cor-
relation showed a negative linear relationship between
the protein expression of MMP-2 and collagen-Iand bet-
ween the protein expression of MMP-9 and collagen-I
(Figure 7).
Discussion
A myocardial collagen networkmainly composed of col-
lagen-I/III, relies on the connection between myocardialFigure 7 Correlation between the protein expression of MMP-2and M
collage-I. Collagen volume fraction refers to the percentage of collagen-I to
expressed as means ± standard error in each sample from Group D using t
negative linear relationship between the protein expression of MMP-2 and
of MMP-9 and collagen-I (r = −0.697, P = 0.049). MMP, matrix metalloproteistructure and a direct correlation to the heart’s global
systolic and diastolic function, and this was first pro-
posed by Borg in 1981[15]. Studies have found that
the deposition of collagenI/III and the imbalance of
collagenI/III are the main components of myocardial
collagen network remodeling [3,16]. The mechanism for
impaired heart function due to interstitial fibrosis recon-
struction is that myocardial collagen remodeling leads
to collagen deposition, an increase in wall stiffness
(decreased compliance), ventricular filling limitation,
stroke volume reduction, severe interstitial fibrosis, re-
striction in the natural movement of myocardial cells,
myocardial capillary bed reduction, residual myocardial
ischemia and, ultimately, systolic and diastolic dysfunc-
tion [17]. Therefore, promoting the degradation of colla-
gen plays an important role in the reduction of ventricular
remodeling.
The major finding of the present study is that right
ventricular hypertrophy, disorganized myocardial cells,
myocardial cell hypertrophy, inflammatory cell infil-
tration, a significant increase in interstitial pink col-
lagen and significant fibrosis in the rat heart model
of CTEPH, were all improved significantly by a daily
supplement of ginsenoside Rg1. That is, ginsenoside
Rg1 partially reversed right ventricular remodeling in
CTEPH rats. The changes in myocardial collagen were
very obvious in right ventricular remodeling. Although
this observation is similar to those made in a recent
study, where daily administration of ginsenoside Rg1
restored morphological change of myocardial fibrosis
[12], this is the first study to show the beneficial ef-
fect of ginsenoside Rg1, the use of which is based on
a previous study that used an experimental model of
hepatic fibrosis [13]. This study also partially reveals
the mechanisms that are involved in the protective
effect of ginsenoside Rg1 on attenuating myocardial
remodeling.MP-9with collagen-I. (A) MMP-2 and collage-I. (B) MMP-9 and
the whole areafrom each of the five random fieldsin each sample
he pathological image analysis system. Pearson’s correlation showed a
collagen-I (r = −0.715, P = 0.038)and between the protein expression
nase.
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the structural architecture and cardiac function, which
go in parallel with an increased expression and activity
of MMPs [3]. MMPs are typical enzymes involved in
myocardial remodeling, of which MMP-2 and MMP-9
play the mostimportant role [18]. MMP-2 and MMP-
9 are gelatinases, which can degrade gelatin and normal
collagen, causing the normal myocardial interstitium to
be replaced by a fibrous myocardial interstitium, enlar-
ging the ventricles and decreasing cardiac function.They
haverecently aroused wide attention fortheir possible
involvement in myocardial remodeling [19,20].
MMP-9has an important effect on myocardial re-
modeling [3,18]. Clinical studies have also found that
MMP-2 activityis closely related to ventricular remode-
ling and heart dysfunction [21,22]. This study showed
that the expression of MMP-2 and MMP-9 was low
butdetectable in normal myocardial tissue, where they
have an important role in the maintenance of the normal
metabolism of myocardial interstitial homeostasis and the
structural integrity of cardiomyocytes and the interstitium.
When the rats suffered from CTEPH and right ven-
tricular hypertrophy, the expression of MMP-2 and
MMP-9 in Group C was significantly lower than that in
Group A, B and D, and was accompanied by significant
myocardial collagen deposition Pearson’s correlation
showed that the expression of MMP-2 and MMP-9 had
a negative linear correlation with the expression of
collagen-I, which is consistent with previous findings [3].
This finding indicated that decreased expression of
MMP-2 and MMP-9 could be one of the mechanisms
leading to collagen remodeling when rats had CTEPH
and right ventricular hypertrophy. After ginsenoside Rg1
intervention, the expression of MMP-2 and MMP-9 in
Group D was significantly higher than in Group C. The
changein the expression of MMP-2 and MMP-9 sug-
gested that ginsenoside Rg1 deterred right ventricular
remodeling in CTEPH, which was possibly achieved by
the upregulation of expression of MMP-2 and MMP-9.
In addition, the beneficial effects of ginsenoside Rg1
on myocardial remodeling need to be furtherstudied due
to the small sample size. The probable side effects of the
compound are unclear in thetreatment of myocardial
remodeling and its mechanism still needs to be proved
in future studies.
Conclusions
In summary, our results from this study showed that
daily supplementation with ginsenoside Rg1 potently at-
tenuated right ventricular hypertrophy and myocardial
remodeling in the rat model of CTEPH. Ginsenoside
Rg1 also upregulated MMP-2 expression in myocardial
tissue. The protective effect of ginsenoside Rg1 on myo-
cardial remodeling may be partly associated with theupregulation of MMP-2 expression. Although our pre-
sent study was performed in an experimental model,
which does not directly predict a response to therapy
in humans, it provides a potentially new therapeutic
target for patients with CTEPHthrough ginsenoside
Rg1 treatment.
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